This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Pennsylvania. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Spyridon Bakas: Innovator in Medical Imaging Technology
Introduction
Spyridon Bakas is a notable inventor based in Philadelphia, PA, who has made significant contributions to the field of medical imaging. His work focuses on the detection of epidermal growth factor receptor (EGFR) mutations in glioblastoma, a critical area in cancer research and treatment.
Latest Patents
Bakas holds a patent for a method titled "In vivo detection of EGFR mutation in glioblastoma via MRI signature consistent with deep peritumoral infiltration." This innovative method involves a computer-implemented approach for detecting EGFR mutation status within the peritumoral edematous tissue of patients. The process includes performing quantitative pattern analysis of magnetic resonance imaging (MRI) data to assess spatial heterogeneity or similarity within the tissue. Based on this analysis, the EGFR mutation status is classified as either negative or positive. The patent also encompasses a non-transitory computer-readable storage medium and a system designed to facilitate this detection.
Career Highlights
Bakas is affiliated with the University of Pennsylvania, where he continues to advance research in medical imaging and its applications in oncology. His work is pivotal in enhancing the accuracy of glioblastoma diagnosis and treatment planning.
Collaborations
Some of his notable collaborators include Donald O'Rourke and Christos Davatzikos, who are also prominent figures in the field of medical research and imaging.
Conclusion
Spyridon Bakas is a distinguished inventor whose innovative methods are paving the way for improved cancer diagnostics. His contributions to the detection of EGFR mutations in glioblastoma highlight the importance of technology in advancing medical science.